(Sharecast News) - Novacyt announced on Monday that it has conditionally agreed to acquire Southern Cross Diagnostics for an initial cash consideration of AUD 8.5m (£4.45m), as the molecular diagnostics group looked to expand its footprint in the fast-growing Australian market and accelerate its path to profitability.
The AIM-traded company said...

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE